Michael Nedelcovych Profile - TD Cowen Analyst
123 Followers
Michael Nedelcovych's Stock Coverage
| JNJJohnson & Johnson | Oct 19, 2026 | BUY | Reiterated | $300.00 | 4Ratings | +12.80% | ||
| 4568Daiichi Sankyo Company | Sep 28, 2026 | BUY | Reiterated | ¥3,590.00 | 2Ratings | -20.70% | ||
| NVONovo Nordisk | Sep 22, 2026 | HOLD | Reiterated | $42.00 | 32Ratings | -27.64% | ||
| RPRXRoyalty Pharma | Sep 08, 2026 | BUY | Assigned | $68.00 | 11Ratings | +41.93% | ||
| APTXApotex Health Corp. | Jul 06, 2026 | BUY | Initiated | C$40.00 | 1Ratings | -0.20% | ||
| TAKTakeda Pharmaceutical Company | Jun 04, 2026 | BUY | Reiterated | $21.00 | 14Ratings | +15.32% | ||
| CHRSCoherus Biosciences | May 28, 2026 | BUY | Reiterated | ― | 13Ratings | -4.31% | ||
| BHCBausch Health Companies | Apr 30, 2026 | HOLD | Reiterated | C$9.93 | 9Ratings | ― | ― | |
| MOLNMolecular Partners AG | Mar 16, 2026 | BUY | Reiterated | CHF15.00 | 6Ratings | -1.94% | ||
| 4502Takeda Pharmaceutical Co | May 21, 2025 | BUY | Reiterated | ¥5,135.00 | 1Ratings | +29.10% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Michael Nedelcovych activity FAQ
What is the performance of Michael Nedelcovych's recommendations?
The percentage of profitable recommendations made by Michael Nedelcovych is 47.83%, and the average return per transaction is -0.20%.
What stocks does Michael Nedelcovych cover?
What was Michael Nedelcovych's most profitable rating?
Michael Nedelcovych’s most profitable rating was a buy on Coherus Biosciences stock on May 14, 2025. The return on the trade was 106.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here